Tango Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
TNGX
CUSIP
87583X109
Type
Equity
Class
COM
Num filings
260
Total reported value, excl. options
$6.73 B
Manager Report Date Value ($000) Shares Option Type